ArticleScientific reports2026
Comparison of seprafilm and pitavastatin treatments in an experimental model of peritoneal adhesion.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peritoneal adhesions are common following abdominal surgery and lead to significant morbidity. Both pharmacological agents and barrier methods have been investigated for prevention, but with limited success. In this study, the efficacy of intraperitoneal pitavastatin was evaluated and compared with Seprafilm. Thirty-two female Wistar albino rats were randomly divided into four groups (n = 8): control, saline, pitavastatin (30 mg/kg intraperitoneal), and Seprafilm (30 × 20 mm). Macroscopic adhesions were graded using the Majuzi classification, and microscopic adhesions were assessed using the Zühlke scoring system. Plasma SCUBE1, malondialdehyde, and tissue-type plasminogen activator levels were analyzed. Macroscopic evaluation showed that adhesions were predominantly grade 2 in the control group (62.5%) and the saline group (75%). In contrast, a partial reduction in adhesion severity was observed in both the pitavastatin and Seprafilm groups; 25% of patients in both groups showed no adhesions (grade 0). Lower-grade adhesions (grades 1-2) were observed more frequently in these treatment groups. Microscopically, all rats in the control and Seprafilm groups were classified as stage 2 according to the Zühlke grading system. While grade 1 adhesions were predominantly observed in the saline group (87.5%), a broader distribution was observed in the pitavastatin group, including grade 1 (25%), grade 2 (50%), and grade 3 (25%) adhesions. Biochemical analysis revealed no significant differences among groups in plasma SCUBE1 (p = 0.294) and malondialdehyde levels (p = 0.051). However, plasma tissue-type plasminogen activator levels were significantly higher in the control group compared with both the pitavastatin (p = 0.012) and Seprafilm groups (p = 0.027). Intraperitoneal pitavastatin has demonstrated efficacy comparable to that of Seprafilm; however, neither treatment provided a statistically significant protective effect against postoperative peritoneal adhesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.